Stay updated on Safety & Immune Response of eOD-GT8 & g28v2 mRNA-1644 Clinical Trial
Sign up to get notified when there's something new on the Safety & Immune Response of eOD-GT8 & g28v2 mRNA-1644 Clinical Trial page.

Latest updates to the Safety & Immune Response of eOD-GT8 & g28v2 mRNA-1644 Clinical Trial page
- Check7 days agoChange DetectedThe page footer now shows Revision: v3.6.2 instead of v3.6.0, indicating a backend/content management update rather than a substantive change to the study details.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe page adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and introduces explicit Last Verified and Last Known Status Was fields, along with a new Revision: v3.6.0 label. Older labels such as Verified and Last known status was:, and Intervention / Treatment are removed or reformatted; Intervention / Treatment is replaced by Intervention/Treatment, with the page revision updating from v3.5.5 to v3.6.0.SummaryDifference1%

- Check28 days agoChange DetectedThe revision label updated from v3.5.4 to v3.5.5, signaling a page version bump tied to an update of the build or metadata rather than substantive study content.SummaryDifference0.1%

- Check42 days agoChange DetectedPage revision updated from v3.5.3 to v3.5.4, indicating a new version of the page. This change appears in the footer and does not alter the study details presented to users.SummaryDifference0.1%

- Check57 days agoChange DetectedThe page now includes a status metadata block with the last known status, the contributing organization (International AIDS Vaccine Initiative), and the verification date (2024-04). This addition adds context about who verified the status and when.SummaryDifference0.4%

- Check64 days agoChange DetectedThe page revision tag was updated from Revision: v3.5.2 to Revision: v3.5.3, indicating a newer version of the page. This update does not change any study content or user-facing details.SummaryDifference0.1%

Stay in the know with updates to Safety & Immune Response of eOD-GT8 & g28v2 mRNA-1644 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety & Immune Response of eOD-GT8 & g28v2 mRNA-1644 Clinical Trial page.